PharmaCielo Ltd. announced that experienced financial and cannabis executive Ian D. Atacan has been appointed Chief Financial Officer of the Company, effective June 7, 2021, to replace CFO Scott Laitinen, who is retiring, effective June 1, 2021. Mr. Atacan is a finance leader with more than 25 years of experience in strategy, M&A, and financing. Most recently, Mr. Atacan was the Chief Financial Officer of Blueberries Medical Corp. Previously, he was the CFO of Natura Naturals Holdings Inc. Prior to that, Mr. Atacan served as CFO of Global Atomic Corporation under the Cannabis Act of Canada, until its acquisition by Tilray Inc.